1BP-LSD Blotters 400mcg

In the field of specifically modified lysergamides, 1BP-LSD, through its dioxaborolane unit, serves as a direct, legal successor for a group of formerly popular but now prohibited derivatives. In laboratory practice, it substitutes as of now:

• ETH-LAD (6-Ethyl-6-nor-lysergic acid diethylamide)
• AL-LAD (6-Allyl-6-nor-lysergic acid diethylamide)
• 1cP-AL-LAD
• 1D-AL-LAD
• 1T-AL-LAD

Researchers who previously worked with these substances will find in the 1BP-LSD molecule the modern equivalent for continued structure-activity relationship analyses under current legislation.

Structural differentiation from related compounds manifests in a specific substitution at the N1-indole nitrogen. At this position, a benzoyl group is attached, which in turn is substituted with a dioxaborolane ring. This boron-containing complex significantly distinguishes the compound from traditionally regulated derivatives. The inclusion of this structurally sophisticated semi-metal cluster serves chemical stabilization and determines the legal status for in-vitro analytics.

In biochemical nomenclature, 1BP-LSD is classified as a prodrug. This implies the following parameters:

• The isolated compound possesses almost no significant pharmacological receptor affinity in an in-vitro environment.
• Transformation to the pharmacologically active base compound occurs exclusively in-vivo through enzymatic hydrolysis processes.
• This metabolism correlates with the known degradation pathways of earlier analogs (including 1S-LSD, 1D-LSD, 1V-LSD).

Despite metabolic parallels to 1P-LSD or 1Fe-LSD, empirical laboratory data indicate specific pharmacokinetic variances:

• Delayed Hydrolysis Rate: Compared to ALD-52, 1cP-LSD, or 1P-LSD, current data suggests a slowed enzymatic degradation process (onset).
• Semi-metal Substitution: The integration of the dioxaborolane unit introduces a semi-metal (boron) into the molecular structure. In direct comparison to transition metal-based derivatives (such as the ferrocene system in 1Fe-LSD), this results in divergent physicochemical properties relevant for specific chemical analysis approaches.

Exact quantification in laboratory setups requires consideration of the specific molecular weight. The boron-containing addition significantly increases the molar mass compared to precursor substances, making a stoichiometric correction of input quantities mandatory. The theoretical release rate for a base quantity of 250µg 1BP-LSD-Tartrate behaves as follows:

To achieve the molecular release of conventional standard dosages in practice, a calibration to 400mcg 1BP-LSD is often performed due to the steric expansion of the molecule.

Maintaining the structural integrity of this complex organic compound requires specific laboratory precautions. Contrary to common assumptions, however, the derivative exhibits solid basic stability against environmental factors (resistant to moderate heat, oxygen, and UV light).

• Thermal Factors: The substance tolerates moderate temperature fluctuations. For long-term archiving, storage at a constant room temperature is recommended. For cyclic analyses (use within 4 weeks), regular dry storage is sufficient.
• Hygroscopy & Condensation: Protection against moisture is a priority. If optional cold storage is used, hermetic sealing is indispensable. To avoid condensation on the paper carrier, the container must reach room temperature before opening.
• UV Stability: Storage in amber glass vessels is recommended to minimize potential photonic degradation (optional).
• Mechanical Handling (Carrier Medium): The active ingredient is present in a deep, homogeneous impregnation of the special paper fibers. Handling must be carried out exclusively with laboratory gloves. This measure serves to prevent cross-contamination by cutaneous lipids or sweat, which could falsify analytical purity in the spectrometer.
• Mass Correction Factor: The declared mass (e.g., 250mcg) refers to the complete 1BP-LSD-Tartrate salt including the dioxaborolane adduct. For exact molar comparisons with the base molecule LSD-25, the weight of the functional group must be mathematically subtracted (see equivalence values).